Hypertension Clinical Trials in Philadelphia

Showing 1-20 of 143 trials

Penn Medicine Healthy Heart

NCT06062394

To leverage access to patients across the primary care network, EPIC tools for identifying eligible patients, and the Way to Health platform to launch and enroll a program that will be evaluated in a clinical trial that is focused on changing patient behavior and powered to detect differences in improving blood pressure and cholesterol over 6 months for Penn Medicine patients in West/Southwest Philadelphia and Lancaster.

HypertensionHyperlipidemias

University of Pennsylvania1,980 participantsStarted Mar 2024

Philadelphia, Pennsylvania, United States

ACTIVE_NOT_RECRUITINGNA< 1 mile

Safety and Impact of Low Resistance Exercise Training on Quality of Life in Pulmonary Arterial Hypertension

NCT06543745

The purpose of the study is to learn more about how low-resistance training impacts frailty and the quality of life of people with pulmonary arterial hypertension (PAH). Low-resistance training is an evidence-based approach that may help patients improve their functional ability.

Pulmonary Arterial HypertensionFrailty

University of Pennsylvania20 participantsStarted Sep 2024

Philadelphia, Pennsylvania, United States

ACTIVE_NOT_RECRUITINGPHASE3< 1 mile

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

NCT06274801

This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study

Pulmonary Arterial Hypertension

GB002, Inc.316 participantsStarted Sep 2024

Fresno, California, United States • Los Angeles, California, United States • Sacramento, California, United States +112 more locations

Penn Medicine Healthy Heart

Safety and Impact of Low Resistance Exercise Training on Quality of Life in Pulmonary Arterial Hypertension

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

Hypertension Trials in Other Cities

Gamification to Increase Mobility in the Hospital

The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)

Gamification and Medication Adherence (GAME Adherence)

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Addressing Hypertension Care in Africa Program

An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.

A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

Other Conditions in Philadelphia